Average Co-Inventor Count = 12.97
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Revolution Medicines, Inc. (10 from 35 patents)
2. Exelixis, Inc. (9 from 172 patents)
19 patents:
1. 12365688 - Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors
2. 12258366 - Bicyclic heteroaryl compounds and uses thereof
3. 11739093 - Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors
4. 11702411 - Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors
5. 11690915 - Ras inhibitors
6. 11673901 - Polycyclic compounds as allosteric SHP2 inhibitors
7. 11673896 - Pyridine compounds as allosteric SHP2 inhibitors
8. 11661401 - 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
9. 11597699 - MEK inhibitors and methods of their use
10. 11168102 - Bicyclic heteroaryl compounds and uses thereof
11. 10590090 - 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
12. 8637499 - Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture
13. 8440663 - 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as JAK-2 modulators and methods of use
14. 8362002 - Azetidines as MEK inhibitors for the treatment of proliferative diseases
15. 8324231 - Pyrimidinones as casein kinase II (CK2) modulators